Treatment of advanced pancreatic cancer (APC) with gemcitabine as a single agent: a multicentre trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F00%3A00000024" target="_blank" >RIV/00209805:_____/00:00000024 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Treatment of advanced pancreatic cancer (APC) with gemcitabine as a single agent: a multicentre trial
Original language description
Results of multicentre trial with gemcitabine as monotherapy of advanced pancreatic cancer are evaluated. This paliative therapy had good clinical benefit.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2000
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of Oncology
ISSN
0923-7534
e-ISSN
—
Volume of the periodical
11
Issue of the periodical within the volume
suppl. 4
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
1
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—